Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Where we are now as ONCY shareholders

<< Previous

Bullboard Posts

Next >>

Comment by Buckhenryon Dec 27, 2022 6:22pm

121 Views

Post# 35192887

RE:Where we are now as ONCY shareholders

can you imagine if everyone on here was an unnoteable. then they would get into it over who has the biggest ego and posts the most. as long as you have 2 our mote people here is always going to be strife. the world would be a better place if we could just got rid of people!!!!! lol

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market